Harvoni 400/90mg 28 Tablets

47,139.30 SAR

  • Brand: Harvoni
  • Genuine  brands

    Genuine brands


  • Temperature Controlled

    Temperature Controlled


  • Secure Payment

    Secure Payment

About Product

Product Description:




  • The fixed-dose combination of ledipasvir-sofosbuvir and provides an effective and well-tolerated one-pill once-a-day option for treatment of genotypes 1, 4, 5, and 6 chronic hepatitis C (HCV) infection.




  • This direct-acting antiviral regimen was the first FDA-approved interferon- and ribavirin-free regimen to treat hepatitis C.




  • Ledipasvir-sofosbuvir can be used without ribavirin in most patients with genotype 1A, except those who are cirrhotic and treatment-experienced.




  • In addition, persons with HCV genotype 1 may be eligible for an 8-week duration if they are treatment-naïve, without cirrhosis, and have a pretreatment HCV RNA level less than 6 million. Similar to sofosbuvir-velpatasvir, the other NS5B-NS5A inhibitor combination, ledipasvir-sofosbuvir is safe and effective for the treatment of HCV in persons with decompensated cirrhosis.




How to use:




  • Ledipasvir-sofosbuvir (90 mg/400 mg) is a fixed-dose combination tablet.




  • The recommended dosage is one tablet once daily, with or without food.




Caution & Warnings:




  • Risk of HBV reactivation in patients coinfected with HCV and HBV.




Side Effects:



  • Fatigue and headache.


Ingredients:



  • Ledipasvir, sofosbuvir 90mg/400mg.

Product Details:

  • Brand: Harvoni
Get prescription for your medicineGet prescription for your medicine